top of page

Male, 84, 5-year survivor of prostate cancer from Macedonia 男性,84岁,来自马其顿的前列腺癌五年幸存者


prostate cancer

We are thrilled to share the incredible success story of Pavle, a five-year survivor of prostate cancer from Macedonia. At the age of 80, Pavle received a devastating diagnosis of malignant prostate cancer, which left him with limited treatment options due to his inability to undergo chemotherapy.

我们非常高兴地分享来自马其顿的前列腺癌五年幸存者帕夫勒的不凡成功故事。当时80岁的帕夫勒接受了前列腺癌的毁灭性诊断,由于无法接受化疗,他的治疗选择受到了严重限制。

However, Pavle's journey took a remarkable turn when he opted for ECCT treatment. With determination and trust in this innovative approach, Pavle embarked on his treatment journey, guided by the expert medical team behind ECCT.

然而,帕夫勒的旅程在他选择ECCT治疗时出现了显著转变。怀着对这种创新方法的决心和信任,帕夫勒启程踏上了他的治疗之旅,由ECCT背后的专业医疗团队指导。

In 2024, at the age of 84, Pavle stands as a shining example of the effectiveness of ECCT. Not only is he cancer-free, but he also enjoys vibrant health and an active lifestyle. His resilience and determination serve as an inspiration to us all.

2024年,84岁的帕夫勒成为ECCT有效性的鲜活证明。他不仅摆脱了癌症,还享受着充满活力的健康和积极的生活方式。他的坚韧和决心为我们所有人树立了榜样。

To anyone facing a similar diagnosis, we encourage you to explore all available treatment options, including ECCT, and to never lose hope in the face of adversity. Pavle's story is a testament to the power of perseverance and the incredible potential of modern medicine. We wish Pavle continued health and happiness in the years to come.

对于面临类似诊断的任何人,我们鼓励您探索所有可用的治疗选择,包括ECCT,并在逆境中永不放弃希望。帕夫勒的故事是对坚持不懈的力量和现代医学的令人难以置信的潜力的证明。我们祝愿帕夫勒未来健康幸福。

Comments


bottom of page